Rating: n/a
Bookmark
Save as PDF
Print
Email
Blog It
Stumble It!
Study likely spells end for anti-bleeding drug
(AP) -- An anti-bleeding drug probably will stay off the market, experts say, after a rigorous study found patients getting the medication during heart surgery were much more likely to die than patients given other drugs.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .
» Next Article in Medicine & Health - Medications: Aprotinin associated with increased risk of death
PhysOrg Forum
Video
Editorials
Free Magazines
Free White Papers
Newsletter
Advanced Search
Goto Archive
Suggest a story idea
Send feedback
